Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/5/2019
SIETES contiene 92751 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Garmendia CA, Gorra LN, Rodríguez AL, Trepka MJ, Veledar E, Madhivanan P. Evaluation of the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses. The example of the apixaban trials. JAMA Intern Med 2019;179:4 de marzo. [Ref.ID 103094]
2. Cita con resumen
Groves T. Big strides in Europe towards clinical trial transparency. BMJ 2014;349:g6276. [Ref.ID 98206]
3. Cita con resumen
Sorenson C, Naci H, Cylus J, Mossialos E. Evidence of comparative efficacy should have a formal role in European drug approvals. BMJ 2011;343:514-7. [Ref.ID 91460]
4.Tiene citas relacionadas Cita con resumen
Nissen SE. Angiotensin-receptor blockers and cancer: urgent regulatory review needed. Lancet Oncol 2010;11:605-6. [Ref.ID 89877]
5.Tiene citas relacionadas Cita con resumen
Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials. Lancet Oncol 2011;12:65-82. [Ref.ID 89446]
6.Tiene citas relacionadas
Weiner DE, Miskulin DC. Anemia management in chronic kidney disease: bursting the hemogloblin bubble. Ann Intern Med 2010;153:53-4. [Ref.ID 88834]
7.Tiene citas relacionadas Cita con resumen
Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GFM. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 2010;153:23-33. [Ref.ID 88832]
8. Cita con resumen
Luepker RV. Drug safety. Are we making progress?. Arch Intern Med 2010;170:202. [Ref.ID 87774]
10.Tiene citas relacionadas Cita con resumen
Reginster J-Y. Calcium and vitamin D for osteoporotic fracture risk. Lancet 2007;370:632-4. [Ref.ID 80787]
11.Tiene citas relacionadas Cita con resumen
Young C, Horton R. Putting clinical trials into context. Lancet 2005;366:107-8. [Ref.ID 74383]
12. Cita con resumen
Topol EJ. Arthritis medicines and cardiovascular events - "House of coxibs". JAMA 2005;293:366-8. [Ref.ID 72541]
13. Cita con resumen
Anónimo. Vioxx should have been pulled sooner, says Lancet. Scrip 2004;3003:26. [Ref.ID 71936]
14.
Ioannidis JPA, Contopoulos-Ioannidis DG, Lau J. Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. J Clin Epidemiol 1999;52:281-91. [Ref.ID 44775]
15.
Egger M, Smith GD, Sterne JAC. Meta-analysis: is moving the goal post the answer?. Lancet 1998;351:1517. [Ref.ID 38638]
17.
18. Cita con resumen
López Arrieta JM, Qizilbash N. La medicina basada en pruebas: revisiones sistemáticas. La Colaboración Cochrane. Med Clin (Barc) 1996;107:581-5. [Ref.ID 29642]
19.Tiene citas relacionadas
Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995;48:45-57. [Ref.ID 23521]
20.
Subtil D, Truffert P, Vinatier D, Puech F, Querleu D, Crepin G. Intérêts et limites des méta-analyses -classiques ou cumulatives- en gynécologie-obstétrique. Therapie 1994;50:175-9. [Ref.ID 22391]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>